$2.85
0.010.35%
At close: -
$2.95
0.103.51%
After Hours: 6:54 PM EDT
Perspective Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Perspective Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.21 | $-0.21 | 0.00 % |
Jun 2024 | 2024-08-12 | $-0.17 | $-0.21 | 19.1 % |
Mar 2024 | 2024-05-15 | $-0.20 | $-0.20 | 0.00 % |
Sep 2023 | 2023-11-14 | $-0.40 | $-0.40 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $369.00K | $170.00K | 117.1 % |
Jun 2024 | 2024-08-12 | $526.00K | $60.00K | 776.7 % |
Sep 2023 | 2023-11-14 | $2.19M | $2.22M | -1.58 % |
Jun 2023 | 2023-08-11 | $2.09M | $2.61M | -20.0 % |
Perspective Therapeutics (CATX) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.21, which hit the estimate of $-0.21.
The Actual Revenue was $369K, which beat the estimate of $170K.
Browse earnings estimates, EPS, and revenue on all stocks.